Kennedy Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.3M | Buy |
484,580
+50,814
| +12% | +$3.58M | 0.66% | 18 |
|
|
2025
Q4 | $29.2M | Buy |
433,766
+50,209
| +13% | +$3.38M | 0.62% | 17 |
|
|
2025
Q3 | $28.1M | Sell |
383,557
-31,719
| -8% | -$2.11M | 0.62% | 17 |
|
|
2025
Q2 | $21.6M | Sell |
415,276
-59,177
| -12% | -$3.37M | 0.52% | 31 |
|
|
2025
Q1 | $30.3M | Buy |
474,453
+80,427
| +20% | +$4.67M | 0.72% | 12 |
|
|
2024
Q4 | $18.8M | Buy |
394,026
+29,484
| +8% | +$1.51M | 0.42% | 42 |
|
|
2024
Q3 | $20.9M | Sell |
364,542
-77,153
| -17% | -$4.42M | 0.46% | 31 |
|
|
2024
Q2 | $23.1M | Sell |
441,695
-71,401
| -14% | -$3.13M | 0.49% | 29 |
|
|
2024
Q1 | $20.9M | Sell |
513,096
-149,720
| -23% | -$5.61M | 0.43% | 40 |
|
|
2023
Q4 | $24.5M | Buy |
662,816
+16,341
| +3% | +$615K | 0.54% | 21 |
|
|
2023
Q3 | $24.7M | Buy |
646,475
+28,880
| +5% | +$1.18M | 0.6% | 15 |
|
|
2023
Q2 | $22.3M | Buy |
617,595
+113,886
| +23% | +$3.89M | 0.52% | 26 |
|
|
2023
Q1 | $19.2M | Sell |
503,709
-70,485
| -12% | -$3.31M | 0.57% | 20 |
|
|
2022
Q4 | $32.7M | Sell |
574,194
-71,579
| -11% | -$3.66M | 0.92% | 1 |
|
|
2022
Q3 | $25.5M | Buy |
645,773
+43,762
| +7% | +$1.93M | 0.75% | 8 |
|
|
2022
Q2 | $26.5M | Buy |
602,011
+39,961
| +7% | +$1.73M | 0.74% | 7 |
|
|
2022
Q1 | $22.4M | Buy |
562,050
+22,308
| +4% | +$795K | 0.53% | 29 |
|
|
2021
Q4 | $21.7M | Sell |
539,742
-8,841
| -2% | -$330K | 0.46% | 39 |
|
|
2021
Q3 | $22.3M | Buy |
548,583
+195,504
| +55% | +$8.17M | 0.5% | 24 |
|
|
2021
Q2 | $16M | Sell |
353,079
-2,398
| -0.7% | -$106K | 0.34% | 70 |
|
|
2021
Q1 | $14.8M | Buy |
355,477
+23,021
| +7% | +$1.05M | 0.3% | 90 |
|
|
2020
Q4 | $14.2M | Sell |
332,456
-1,849
| -0.6% | -$66.5K | 0.32% | 81 |
|
|
2020
Q3 | $8.79M | Sell |
334,305
-2,254
| -0.7% | -$62.8K | 0.25% | 117 |
|
|
2020
Q2 | $9.02M | Sell |
336,559
-6,982
| -2% | -$158K | 0.26% | 108 |
|
|
2020
Q1 | $6.18M | Buy |
343,541
+113,253
| +49% | +$2.15M | 0.23% | 137 |
|
|
2019
Q4 | $4.08M | Buy |
230,288
+62,942
| +38% | +$1.09M | 0.1% | 392 |
|
|
2019
Q3 | $2.6M | Sell |
167,346
-10,174
| -6% | -$168K | 0.06% | 491 |
|
|
2019
Q2 | $3.05M | Sell |
177,520
-141
| -0.1% | -$2.27K | 0.07% | 468 |
|
|
2019
Q1 | $2.86M | Sell |
177,661
-58,405
| -25% | -$946K | 0.07% | 481 |
|
|
2018
Q4 | $3.45M | Sell |
236,066
-358,468
| -60% | -$5.72M | 0.09% | 428 |
|
|
2018
Q3 | $10.8M | Sell |
594,534
-13,655
| -2% | -$239K | 0.2% | 155 |
|
|
2018
Q2 | $10.3M | Buy |
608,189
+93,544
| +18% | +$1.77M | 0.19% | 152 |
|
|
2018
Q1 | $10.1M | Buy |
514,645
+6,667
| +1% | +$129K | 0.2% | 149 |
|
|
2017
Q4 | $10.3M | Sell |
507,978
-57,551
| -10% | -$1.06M | 0.18% | 167 |
|
|
2017
Q3 | $9.82M | Buy |
565,529
+19,329
| +4% | +$262K | 0.18% | 181 |
|
|
2017
Q2 | $7M | Sell |
546,200
-150,245
| -22% | -$2.01M | 0.13% | 264 |
|
|
2017
Q1 | $9.03M | Sell |
696,445
-3,284
| -0.5% | -$41.5K | 0.16% | 218 |
|
|
2016
Q4 | $6.91M | Buy |
699,729
+161,186
| +30% | +$1.77M | 0.12% | 294 |
|
|
2016
Q3 | $6.51M | Buy |
538,543
+417,498
| +345% | +$4.27M | 0.12% | 292 |
|
|
2016
Q2 | $1.04M | Buy |
121,045
+47,364
| +64% | +$467K | 0.02% | 646 |
|
|
2016
Q1 | $698K | Buy |
73,681
+2,818
| +4% | +$26.5K | 0.01% | 680 |
|
|
2015
Q4 | $1.23M | Buy |
70,863
+22,539
| +47% | +$359K | 0.02% | 637 |
|
|
2015
Q3 | $649K | Buy |
48,324
+1,157
| +2% | +$23.2K | 0.01% | 679 |
|
|
2015
Q2 | $1.06M | Buy |
+47,167
| New | +$829K | 0.02% | 665 |
|
Other funds holding HALO
VCM
VPM
Kennedy Capital Management's HALO Position: Q1 2026 in Review
Kennedy Capital Management increased its Halozyme (HALO) stake by 12% in Q1 2026, buying an estimated $3.58M and bringing the position to 484,580 shares worth $31.3M. The position accounts for 0.66% of the portfolio, ranked #18.
Kennedy Capital Management first reported a position in HALO in Q2 2015 and has held it in 44 quarters since. The position peaked at $32.7M in Q4 2022. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Kennedy Capital Management held 484,580 shares of Halozyme worth $31.3M as of Q1 2026.
- Kennedy Capital Management bought 50,814 Halozyme shares in Q1 2026, an estimated $3.58M.
- Halozyme made up 0.66% of Kennedy Capital Management's portfolio in Q1 2026, its #18 holding.
- Kennedy Capital Management first reported a position in Halozyme in Q2 2015 and has held it in 44 quarters since.
- Kennedy Capital Management's Halozyme position peaked at $32.7M in Q4 2022.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.